SWOG clinical trial number
SWOG-9061 (EST-2190) (INT-0121)
A Phase III Study of Conventional Adjuvant Chemotherapy versus High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation as Adjuvant Intensification Therapy Following Conventional Adjuvant Chemotherapy in Patients with Stage II and III Breast Cancer at High Risk of Recurrence
Closed
Phase
Published
Abbreviated Title
A Phase III Study of Conventional Adjuvant Chemotherapy versus High Dose Chemotherapy and Autologous Bone Marrow or Stem Cell Transplantation as Adjuvant Intensification Therapy Following…
Activated
01/15/1992
Closed
08/03/1998
Publication Information Expand/Collapse
2003
Phase III study of conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in patients with stage II and III breast cancer at high risk of recurrence (INT 0121)
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer